Table 2.
Number of Events by Treatment Arm
| Total Number of Events |
Among Subjects Who Had 1 Event |
Among Subjects Who Had >1 Event |
||||
|---|---|---|---|---|---|---|
| Event | Inhaled Treprostinil (n = 89) | Placebo (n = 109) | Inhaled Treprostinil (n = 54) | Placebo (n = 51) | Inhaled Treprostinil (n = 35) | Placebo (n = 58) |
| Decline in 6MWD ⩾ 15% | 45 | 64 | 21 | 19 | 24 | 45 |
| Exacerbation | 48 | 72 | 11 | 15 | 37 | 57 |
| Decline in FVC ⩾ 10% | 19 | 33 | 10 | 13 | 9 | 20 |
| Cardiopulmonary hospitalization | 23 | 33 | 6 | 4 | 17 | 29 |
| Lung transplantation | 2 | 1 | 1 | 0 | 1 | 1 |
| Death | 10 | 12 | 5 | 0 | 5 | 12 |
| Total | 147 | 215 | 54 | 51 | 93 | 164 |
Definition of abbreviation: 6MWD = 6-minute-walk distance.